Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUMIERE: Alisertib vs Investigator's Choice in Relapsed/Refractory PTCL
NCT01482962Phase 3Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Jun 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 31
01
Overview
A Phase 3 trial of alisertib in peripheral T-cell lymphoma (PTCL), sponsored by Millennium Pharmaceuticals. Started Jun 2012; status: completed.
02
Drugs
alisertib
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01482962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01482962.